A myo-inositol diet for lung cancer prevention and beyond

Affiliations

Editorial

Jae-Il Roh et al. J Thorac Dis. 2018 Nov.

. 2018 Nov;10(Suppl 33):S3919-S3921.

doi: 10.21037/jtd.2018.08.143.

¹ Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Republic of Korea.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.
Unver N, Delgado O, Zeleke K, Cumpian A, Tang X, Caetano MS, Wang H, Katayama H, Yu H, Szabo E, Wistuba II, Moghaddam SJ, Hanash SM, Ostrin EJ. Unver N, et al. Int J Cancer. 2018 Apr 1;142(7):1405-1417. doi: 10.1002/ijc.31152. Epub 2017 Dec 23. Int J Cancer. 2018. PMID: 29134640 Free PMC article.

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7-30. 10.3322/caac.21387 - DOI - PubMed
1. Bittner N, Ostoros G, Geczi L. New treatment options for lung adenocarcinoma--in view of molecular background. Pathol Oncol Res 2014;20:11-25. 10.1007/s12253-013-9719-9 - DOI - PubMed
1. Jhaveri KD, Perazella MA. Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med 2018;378:1163. 10.1056/NEJMc1801663 - DOI - PubMed
1. Regidor PA, Schindler AE. Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. Int J Endocrinol 2016;2016:9537632. 10.1155/2016/9537632 - DOI - PMC - PubMed
1. Levine J. Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 1997;7:147-55. 10.1016/S0924-977X(97)00409-4 - DOI - PubMed